Pfizer's revenues in the U.S. and abroad 2009-2022

Revenues generated from outside of the United States accounted for almost two thirds of Pfizer's total revenue in 2022. During that year, the company generated revenues of roughly 58 billion U.S. dollars in countries outside of the United States.

China emerges as important market

Pfizer sells its pharmaceutical products in more than 120 countries worldwide, with the United States, China, and Japan being among the major national markets. In 2022, the United States alone contributed a share of more than 42 percent. In terms of geographic area, emerging markets – which includes China – generated revenues of approximately 20 billion U.S. dollars in 2022.

Analyzing Pfizer’s global operations

In 2022, Pfizer had approximately 83,000 employees worldwide and properties in approximately 90 countries. The American company had more than 40 manufacturing sites in countries ranging from Belgium to Singapore, each producing products that service the company’s commercial division. Pfizer also had several facilities that focused on research and development projects, many of which were located in North America.